ACM
CRL icon

Argent Capital Management’s Charles River Laboratories CRL Stock Holding History

Argent Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-145,357
Closed -$30M – 155
2024
Q2 		$30M Sell
145,357
-1,895
-1% -$429K 0.88% 37
2024
Q1 		$39.9M Buy
147,252
+85,300
+138% +$20.4M 1.16% 32
2023
Q4 		$14.6M Sell
61,952
-93,821
-60% -$18.5M 0.48% 52
2023
Q3 		$30.5M Sell
155,773
-12,617
-7% -$2.59M 1.09% 33
2023
Q2 		$35.4M Sell
168,390
-3,779
-2% -$752K 1.15% 33
2023
Q1 		$34.7M Buy
172,169
+1,938
+1% +$439K 1.2% 35
2022
Q4 		$37.1M Buy
170,231
+780
+0.5% +$170K 1.33% 29
2022
Q3 		$33.3M Buy
169,451
+158,627
+1,466% +$34.2M 1.31% 28
2022
Q2 		$2.32M Sell
10,824
-134
-1% -$32.7K 0.09% 83
2022
Q1 		$3.11M Buy
10,958
+110
+1% +$33.9K 0.1% 74
2021
Q4 		$4.09M Buy
10,848
+176
+2% +$68.4K 0.12% 71
2021
Q3 		$4.4M Buy
10,672
+182
+2% +$75.6K 0.14% 64
2021
Q2 		$3.88M Buy
10,490
+570
+6% +$190K 0.12% 69
2021
Q1 		$2.88M Buy
9,920
+36
+0.4% +$10K 0.1% 77
2020
Q4 		$2.47M Buy
9,884
+1,092
+12% +$260K 0.09% 79
2020
Q3 		$1.99M Buy
8,792
+911
+12% +$189K 0.08% 80
2020
Q2 		$1.37M Buy
+7,881
New +$1.26M 0.06% 99

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Argent Capital Management's CRL Position: Q3 2024 in Review

Argent Capital Management sold out of Charles River Laboratories (CRL) in Q3 2024, closing a stake of 145,357 shares — an estimated $30M sold.

Argent Capital Management first reported a position in CRL in Q2 2020 and held it in 17 quarters. The position peaked at $39.9M in Q1 2024. 628 funds tracked by Wall St. Rank hold CRL as of Q3 2024.

  • Argent Capital Management reported no remaining Charles River Laboratories position as of Q3 2024 after selling out during the quarter.
  • Argent Capital Management sold 145,357 Charles River Laboratories shares in Q3 2024, an estimated $30M.
  • Argent Capital Management first reported a position in Charles River Laboratories in Q2 2020 and held it in 17 quarters.
  • Argent Capital Management's Charles River Laboratories position peaked at $39.9M in Q1 2024.
  • 628 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2024.

Based on Argent Capital Management's 13F filing for Q3 2024, filed 23 Oct 2024.